InterOcean Capital LLC trimmed its stake in shares of Colgate-Palmolive (NYSE:CL) by 32.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,486 shares of the company’s stock after selling 2,169 shares during the quarter. InterOcean Capital LLC’s holdings in Colgate-Palmolive were worth $298,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of CL. Checchi Capital Advisers LLC raised its holdings in shares of Colgate-Palmolive by 2.2% in the 4th quarter. Checchi Capital Advisers LLC now owns 7,594 shares of the company’s stock valued at $523,000 after purchasing an additional 164 shares in the last quarter. Kingsview Wealth Management LLC purchased a new position in Colgate-Palmolive in the fourth quarter valued at $238,000. First Mercantile Trust Co. raised its stake in Colgate-Palmolive by 6.0% in the fourth quarter. First Mercantile Trust Co. now owns 31,945 shares of the company’s stock valued at $2,199,000 after buying an additional 1,812 shares in the last quarter. Echo Street Capital Management LLC purchased a new stake in Colgate-Palmolive during the 4th quarter worth about $7,982,000. Finally, Sigma Planning Corp boosted its position in shares of Colgate-Palmolive by 7.5% during the 4th quarter. Sigma Planning Corp now owns 8,080 shares of the company’s stock worth $556,000 after acquiring an additional 563 shares in the last quarter. Institutional investors own 74.79% of the company’s stock.
Shares of NYSE CL traded up $0.49 during midday trading on Friday, reaching $70.75. 3,427,409 shares of the company were exchanged, compared to its average volume of 4,410,119. The stock has a market cap of $60.18 billion, a P/E ratio of 24.15, a PEG ratio of 4.62 and a beta of 0.60. Colgate-Palmolive has a 1 year low of $58.49 and a 1 year high of $77.41. The stock has a fifty day simple moving average of $69.93 and a 200 day simple moving average of $69.58. The company has a current ratio of 0.96, a quick ratio of 0.66 and a debt-to-equity ratio of 21.51.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, May 1st. The company reported $0.75 earnings per share for the quarter, topping analysts’ consensus estimates of $0.73 by $0.02. The company had revenue of $4.10 billion during the quarter, compared to analysts’ expectations of $4.07 billion. Colgate-Palmolive had a return on equity of 942.99% and a net margin of 15.86%. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period last year, the firm earned $0.67 EPS. As a group, analysts forecast that Colgate-Palmolive will post 2.87 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, April 20th were issued a dividend of $0.44 per share. The ex-dividend date of this dividend was Friday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.43. This represents a $1.76 annualized dividend and a dividend yield of 2.49%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 62.19%.
In related news, VP Philip G. Shotts sold 666 shares of the stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $75.61, for a total transaction of $50,356.26. Following the completion of the transaction, the vice president now directly owns 41,158 shares of the company’s stock, valued at $3,111,956.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Daniel B. Marsili sold 4,030 shares of the firm’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $75.45, for a total transaction of $304,063.50. Following the completion of the sale, the insider now owns 51,788 shares of the company’s stock, valued at approximately $3,907,404.60. The disclosure for this sale can be found here. Over the last quarter, insiders sold 80,132 shares of company stock worth $5,774,879. 0.78% of the stock is currently owned by insiders.
Several equities research analysts have recently weighed in on the company. Evercore ISI reissued a “buy” rating and set a $80.00 target price on shares of Colgate-Palmolive in a research report on Monday, January 27th. Berenberg Bank reissued a “sell” rating and set a $58.00 price objective on shares of Colgate-Palmolive in a report on Tuesday, February 4th. Credit Suisse Group restated a “sell” rating and issued a $67.00 target price on shares of Colgate-Palmolive in a report on Monday, May 4th. Stifel Nicolaus lifted their price target on shares of Colgate-Palmolive from $72.00 to $75.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Finally, Citigroup boosted their price target on shares of Colgate-Palmolive from $71.00 to $78.00 and gave the company a “neutral” rating in a research report on Monday, February 3rd. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and ten have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $75.60.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Story: What is the CAC 40 Index?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.